Heart Center and Beijing Key Laboratory of Hypertension, Chaoyang Hospital, Capital Medical University, Beijing, China.
Division of Prevention and Community Health, National Center for Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, National Clinical Research Center of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
J Clin Hypertens (Greenwich). 2020 Apr;22(4):623-630. doi: 10.1111/jch.13838. Epub 2020 Mar 9.
The purpose of this study was to assess the association of blood pressure (BP) measurements with the risk of cardiovascular disease (CVD) and examine whether central systolic BP (CSBP) predicts CVD better than brachial BP measurements (SBP and pulse pressure [PP]). Based on a cross-sectional study conducted in 2009-2010 with follow-up in 2016-2017 among 35- to 64-year-old subjects in China, we evaluated the performance of non-invasively predicted CSBP over brachial BP measurements on the first CVD events. Each BP measurement, individually and jointly with another BP measurement, was entered into the multivariate Cox proportional-hazards models, to examine the predictability of central and brachial BP measurements. Mean age of participants (n = 8710) was 50.1 years at baseline. After a median follow-up of 6.36 years, 187 CVD events occurred. CSBP was a stronger predictor for CVD than brachial BP measurements (CSBP, 1-standard deviation increment HR = 1.49, 95%CI: 1.31-1.70). With CSBP and SBP entering into models jointly, the HR for CSBP and SBP was 1.28 (1.04-1.58) and 1.22 (0.98-1.50), respectively. With CSBP and PP entering into models jointly, the HR for CSBP and PP was 1.51 (1.28-1.78) and 0.98 (0.83-1.15), respectively. For subgroup analysis, the association of CSBP with CVD was stronger than brachial BP measurements in women, those with hypertension and obesity. In the middle-aged Chinese population, noninvasively estimated CSBP may offer advantages over brachial BP measurements to predict CVD events, especially for participants with higher risk. These findings suggest prospective assessment of CSBP as a prevention and treatment target in further trials.
本研究旨在评估血压(BP)测量与心血管疾病(CVD)风险的关联,并探讨中心收缩压(CSBP)是否比肱动脉血压(SBP 和脉搏压[PP])更能预测 CVD。该研究基于 2009-2010 年进行的一项横断面研究,对中国 35-64 岁人群进行随访,于 2016-2017 年评估了非侵入性预测 CSBP 对首次 CVD 事件的表现。将每个 BP 测量值(单独和与另一个 BP 测量值联合)分别纳入多元 Cox 比例风险模型,以检验中心和肱动脉 BP 测量值的预测能力。参与者(n=8710)的平均年龄为基线时的 50.1 岁。中位随访 6.36 年后,发生了 187 例 CVD 事件。CSBP 对 CVD 的预测作用强于肱动脉 BP 测量值(CSBP,每增加 1 个标准差 HR=1.49,95%CI:1.31-1.70)。当 CSBP 和 SBP 同时进入模型时,CSBP 和 SBP 的 HR 分别为 1.28(1.04-1.58)和 1.22(0.98-1.50)。当 CSBP 和 PP 同时进入模型时,CSBP 和 PP 的 HR 分别为 1.51(1.28-1.78)和 0.98(0.83-1.15)。亚组分析显示,CSBP 与 CVD 的相关性在女性、高血压和肥胖患者中强于肱动脉 BP 测量值。在中年中国人群中,非侵入性估计的 CSBP 可能比肱动脉 BP 测量值更能预测 CVD 事件,尤其是对于风险较高的患者。这些发现表明,在进一步的试验中,前瞻性评估 CSBP 作为预防和治疗靶点可能具有优势。